PFE logo

PFE
Pfizer Inc

106,108
Mkt Cap
$257.13B
Volume
72.65M
52W High
$27.69
52W Low
$20.92
PE Ratio
19.76
PFE Fundamentals
Price
$26.49
Prev Close
$26.78
Open
$26.76
50D MA
$25.57
Beta
0.42
Avg. Volume
49.52M
EPS (Annual)
$1.36
P/B
1.64
Rev/Employee
$772,580.25
Loading...
Loading...

Earnings Recap

• Reported GAAP EPS of -$0.29 down -514.29% YoY • Reported revenue of $17.56B down -1.16% YoY • Pfizer reaffirms full-year 2026 revenue guidance of $59.5 to $62.5 billion and Adjusted diluted EPS guidance of $2.80 to $3.00, reflecting expected COVID-19 product revenues and LOE impact.

Bullish

Pfizer achieved strong non-COVID operational revenue growth in 2025, driven by strategic investments in R&D and business development. The company also advanced its pipeline with key pivotal study starts and positive clinical trial results.

Bearish

Pfizer experienced operational revenue declines in 2025, driven by lower COVID-19 product sales and incurred $4.4 billion in asset impairment charges. The company also anticipates future revenue impacts from LOE and drug pricing policies.

Latest PFE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.